These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1282633)

  • 1. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors.
    Schrör K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S68-73. PubMed ID: 1282633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting enzyme inhibitors and the interaction between kinins and eicosanoids.
    Schrör K
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S60-8. PubMed ID: 1697363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin-mediated actions of the renin-angiotensin system.
    Schrör K
    Arzneimittelforschung; 1993 Feb; 43(2A):236-41. PubMed ID: 8498970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
    Mombouli JV; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
    Kramer HJ; Glänzer K; Meyer-Lehnert H; Mohaupt M; Predel HG
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S91-8. PubMed ID: 1697369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors.
    Hecker M; Pörsti I; Busse R
    Braz J Med Biol Res; 1994 Aug; 27(8):1917-21. PubMed ID: 7749381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: possible roles of bradykinin and prostaglandins.
    Schwieler JH; Hjemdahl P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S39-46. PubMed ID: 1282628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
    Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
    Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
    Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
    Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
    Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal vascular responses of bradykinin in the isolated rat kidney].
    Bagate K; Develioglu L; Michel B; Grima M; Imbs JL; Barthelmebs M
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1131-4. PubMed ID: 9404422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
    Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
    Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.